Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

NEW YORK/WINNIPEG (Reuters) – Valeant Pharmaceuticals International Inc (VRX.TO) is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a

9
Like
Save

Comments

Write a comment

*